Skip to main content
. 2019 Dec 26;14:297. doi: 10.1186/s13023-019-1264-5

Table 1.

Clinical and genetic data of 151 Chinese patients with primary hypertrophic osteoarthropathy

Patients without GI involvement (N = 125) Patients with GI involvement (N = 26) P value
Age of onset 14.2 ± 4.2 15.4 ± 5.3 0.293
Age of diagnosis 23.7 ± 8. 25.9 ± 5. 0.158
Sex (Male) 92.8%(116/125) 100%(26/26) 0.244
Subtype 0.419
 1 73.6%(92/125) 84.6%(22/26)
 2 23.2%(29/125) 11.5%(3/26)
 3 3.2%(4/125) 3.8%(1/26)
Family history 16.8%(21/125) 23.1%(6/26) 0.588
Pachydermia 88.0%(110/125) 96.2%(25/26) 0.507
Cutis verticis gyrate 52.9%(63/119) 60.0%(15/25) 0.444
Eczema 3.2%(4/124) 4.0%(1/25) 0.543
Seborrhea 57.3%(71/124) 73.1%(19/26) 0.157
Acne 25.0%(29/116) 48.0%(12/25) 0.022
Hidrosis 70.2%(87/124) 61.5%(16/26) 0.861
Ptosis 5.5%(6/109) 9.5%(2/21) 0.621
Digital clubbing 99.2%(124/125) 96.2%(25/26) 0.375
Joint hypertrophy 95.1%(116/122) 92.3%(24/26) 0.679
Joint pain 40.0%(50/125) 50.0%(13/26) 0.347
Periostosis 96%(120/125) 96.2%(25/26) 1.000
Osteolysis 14.2%(17/120) 19.2%(5/26) 0.547
Bone age delay 1.0%(1/103) 0(0/20) 1.000
Cranial suture widening/delayed closure of the fontanelle 3.1%(3/96) 4.5%(1/22) 0.567
Hypoevolutism 0.8%(1/125) 0(0/26) 1.000
Anemia 4.5%(5/112) 40%(10/25) < 0.001
Hypoalbuminemia 0.9%(1/112) 16.7%(4/24) 0.003
Myelofibrosis 0.9%(1/112) 19.0%(4/21) 0.002
Mutation of SLCO2A1 67.6%(23/34) 86.7%(13/15) 0.293